These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 9850359)

  • 1. Efficacy of chlorofluorocarbon-free beclomethasone dipropionate 400 micrograms day-1 delivered as an extrafine aerosol in adults with moderate asthma.
    Matthys H; Nowak D; Hader S; Kunkel G
    Respir Med; 1998 Jun; 92 Suppl A():17-22. PubMed ID: 9850359
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hydrofluoroalkane-134a beclomethasone dipropionate extrafine aerosol provides equivalent asthma control to chlorofluorocarbon beclomethasone dipropionate at approximately half the total daily dose.
    Davies RJ; Stampone P; O'Connor BJ
    Respir Med; 1998 Jun; 92 Suppl A():23-31. PubMed ID: 9850360
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Safety of hydrofluoroalkane-134a beclomethasone dipropionate extrafine aerosol.
    Thompson PJ; Davies RJ; Young WF; Grossman AB; Donnell D
    Respir Med; 1998 Jun; 92 Suppl A():33-9. PubMed ID: 9850361
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term safety and efficacy of a chlorofluorocarbon-free beclomethasone dipropionate extrafine aerosol.
    Fireman P; Prenner BM; Vincken W; Demedts M; Mol SJ; Cohen RM
    Ann Allergy Asthma Immunol; 2001 May; 86(5):557-65. PubMed ID: 11379808
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hydrofluoroalkane-134a beclomethasone dipropionate, 400 microg, is as effective as chlorofluorocarbon beclomethasone dipropionate, 800 microg, for the treatment of moderate asthma.
    Gross G; Thompson PJ; Chervinsky P; Vanden Burgt J
    Chest; 1999 Feb; 115(2):343-51. PubMed ID: 10027430
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of HFA-beclomethasone dipropionate extra-fine aerosol (800 microg day(-1)) versus HFA-fluticasone propionate (1000 microg day(-1)) in patients with asthma.
    Aubier M; Wettenger R; Gans SJ
    Respir Med; 2001 Mar; 95(3):212-20. PubMed ID: 11266239
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy and safety of beclomethasone dipropionate extrafine aerosol in childhood asthma: a 12-week, randomized, double-blind, placebo-controlled study.
    Nayak A; Lanier R; Weinstein S; Stampone P; Welch M
    Chest; 2002 Dec; 122(6):1956-65. PubMed ID: 12475833
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Extrafine beclomethasone dipropionate breath-actuated inhaler (400 micrograms/day) versus budesonide dry powder inhaler (800 micrograms/day) in asthma.
    Reichel W; Dahl R; Ringdal N; Zetterstrom O; van den Elshout FJ; Laitinen LA
    Int J Clin Pract; 2001 Mar; 55(2):100-6. PubMed ID: 11321849
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy and safety of once or twice daily inhalation of extrafine HFA beclomethasone dipropionate in patients with mild to moderate asthma.
    Gillissen A; Richter A; Oster H; Criée CP
    J Physiol Pharmacol; 2007 Nov; 58 Suppl 5(Pt 1):233-41. PubMed ID: 18204133
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Therapeutic equivalence of inhaled beclomethasone dipropionate with CFC and non-CFC (HFA 134a) propellants both delivered via the Easibreathe inhaler for the treatment of paediatric asthma.
    Farmer IS; Middle M; Savic J; Perri VL; Herdman MJ
    Respir Med; 2000 Jan; 94(1):57-63. PubMed ID: 10714480
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of hydrofluoroalkane-beclomethasone dipropionate Autohaler with budesonide Turbuhaler in asthma control.
    Worth H; Muir JF; Pieters WR
    Respiration; 2001; 68(5):517-26. PubMed ID: 11694816
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effectiveness of low doses (50 and 100 microg b.i.d) of beclomethasone dipropionate delivered as a CFC-free extrafine aerosol in adults with mild to moderate asthma. Study Group.
    Hampel F; Lisberg E; Guérin JC
    J Asthma; 2000 Aug; 37(5):389-98. PubMed ID: 10983616
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Switching from conventional to extrafine aerosol beclomethasone dipropionate therapy in children: a 6-month, open- label, randomized trial.
    Szefler SJ; Warner J; Staab D; Wahn U; Le Bourgeois M; van Essen-Zandvliet EE; Arora S; Pedersen S;
    J Allergy Clin Immunol; 2002 Jul; 110(1):45-50. PubMed ID: 12110818
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acute safety of beclomethasone dipropionate in a new CFC-free propellant system in asthmatic patients.
    Ayres JG; Simmons JL; Stampone P
    Respir Med; 1999 Jan; 93(1):27-32. PubMed ID: 10464845
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy response of inhaled beclomethasone dipropionate in asthma is proportional to dose and is improved by formulation with a new propellant.
    Busse WW; Brazinsky S; Jacobson K; Stricker W; Schmitt K; Vanden Burgt J; Donnell D; Hannon S; Colice GL
    J Allergy Clin Immunol; 1999 Dec; 104(6):1215-22. PubMed ID: 10589004
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Health-related quality of life in moderate asthma: 400 microg hydrofluoroalkane beclomethasone dipropionate vs 800 microg chlorofluorocarbon beclomethasone dipropionate. The Study Group.
    Juniper EF; Buist AS
    Chest; 1999 Nov; 116(5):1297-303. PubMed ID: 10559091
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Equivalence of asthma control with new CFC-free formulation HFA-134a beclomethasone dipropionate and CFC-beclomethasone dipropionate.
    Dahl R; Ringdal N; Ward SM; Stampone P; Donnell D
    Br J Clin Pract; 1997; 51(1):11-5. PubMed ID: 9158265
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A new HFA-134a propellant in the administration of inhaled BDP via the Jet spacer: controlled clinical trial vs the conventional CFC.
    Vondra V; Sladek K; Kotasová J; Terl M; Rossetti A; Cantini L
    Respir Med; 2002 Oct; 96(10):784-9. PubMed ID: 12412977
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Growth, systemic safety, and efficacy during 1 year of asthma treatment with different beclomethasone dipropionate formulations: an open-label, randomized comparison of extrafine and conventional aerosols in children.
    Pedersen S; Warner J; Wahn U; Staab D; Le Bourgeois M; Van Essen-Zandvliet E; Arora S; Szefler SJ;
    Pediatrics; 2002 Jun; 109(6):e92. PubMed ID: 12042586
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of changing the fine particle mass of inhaled beclomethasone dipropionate on intrapulmonary deposition and pharmacokinetics.
    Seale JP; Harrison LI
    Respir Med; 1998 Jun; 92 Suppl A():9-15. PubMed ID: 9850358
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.